What are the major opportunities in the AI In Pharma market? What are the strategies for the AI In Pharma market?

For detailed insights on the major opportunities and strategies in the AI In Pharma market, Read More

How does the AI In Pharma market relate to the overall economy and other similar markets?

For detailed insights on AI In Pharma's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the AI In Pharma market growth? SWOT analysis of the AI In Pharma market.

For detailed insights on the key dynamics influencing the AI In Pharma market growth and SWOT analysis of the AI In Pharma industry, Read More

AI In Pharma Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

AI In Pharma Market Report 2026

Name: AI In Pharma Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

AI In Pharma Market Overview

• AI In Pharma market size has reached to $3.78 billion in 2025

• Expected to grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.4%

• Growth Driver: Cloud-Based Drug Discovery Platforms Propel AI Adoption In Pharma For Enhanced Research And Collaboration

• Market Trend: Companies Embrace Generative AI In Pharma To Enhance Patient Interactions And Record Management

• North America was the largest region in 2025.

What Is Covered Under AI In Pharma Market?

AI in pharma refers to the use of automated algorithms for jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments.

The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning and by drug type into small molecule, and large molecules, by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

What Is The AI In Pharma Market Size and Share 2026?

The AI in pharma market size has grown exponentially in recent years. It will grow from $3.78 billion in 2025 to $4.79 billion in 2026 at a compound annual growth rate (CAGR) of 26.9%. The growth in the historic period can be attributed to growth of pharmaceutical R&D spending, expansion of biomedical data, need for faster drug development, adoption of computational biology, rise of chronic diseases.

What Is The AI In Pharma Market Growth Forecast?

The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to precision medicine adoption, AI based clinical trials, demand for cost efficient drug discovery, growth of personalized therapies, integration of genomics data. Major trends in the forecast period include AI driven drug discovery, clinical trial optimization, predictive disease modeling, real time patient data analytics, automated research and development.

Book your 30 minutes free consultation with our research experts

Global AI In Pharma Market Segmentation

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

Subsegments:

1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems

2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining

3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies

4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models

What Is The Driver Of The AI In Pharma Market?

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy, and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical, and biological data by providing secure data storage options. For instance, in 2025, according to the Eurostat, a Luxembourg-based statistical office of the European Union, in 2023, 45% of EU businesses purchased cloud computing services. Large enterprises were significantly more inclined to adopt cloud solutions than SMEs, with 78% of large businesses using cloud services compared to 44% of SMEs. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma industry growth during the forecast period.

Key Players In The Global AI In Pharma Market

Major companies operating in the AI in pharma market are Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions

Global AI In Pharma Market Trends and Insights

Major companies operating in the AI in pharma market are focusing on developing technological advancements such as AI-powered medical consultation enhancement tools to improve diagnostic accuracy, streamline clinical workflows, and support timely decision-making for healthcare professionals. AI-powered medical consultation enhancement tools use large language models (LLMs) to generate clinical summaries, automate documentation, and interpret patient-provided information to optimize physician efficiency. For instance, in October 2023, Ubie Inc., a Japan-based medical AI startup, introduced a generative AI–driven feature for doctors that streamlines medical record documentation and summarizes patient findings. The feature, known as the medical interview summary function, uses an LLM to automatically condense 20–30 patient responses related to symptoms and lifestyle habits collected through the Ubie Medical Navi platform. By presenting concise summaries directly on the doctor’s screen, the tool allows physicians to quickly understand patient concerns, reduce administrative burden, and improve the overall quality and speed of medical consultations.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The AI In Pharma Market?

In July 2023, BioNTech SE, a Germany-based biotechnology company that develops and manufactures active immunotherapies, acquired InstaDeep for an undisclosed amount. The acquisition aims to enhance BioNTech’s AI-driven drug discovery and development capabilities, accelerating the creation of next-generation immunotherapies and vaccines. InstaDeep is a UK-based technology company specializing in artificial intelligence (AI) and machine learning (ML) solutions.

Regional Insights

North America was the largest region in the AI in pharma market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Pharma Market?

The AI in the pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimizing material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Pharma Market Report 2026?

The ai in pharma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in pharma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

AI In Pharma Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.79 billion
Revenue Forecast In 2035	$11.12 billion
Growth Rate	CAGR of 26.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Technology, Drug Type, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. AI In Pharma Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global AI In Pharma Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. AI In Pharma Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global AI In Pharma Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 AI Driven Drug Discovery

4.2.2 Clinical Trial Optimization

4.2.3 Predictive Disease Modeling

4.2.4 Real Time Patient Data Analytics

4.2.5 Automated Research And Development

5. AI In Pharma Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Firms

5.3 Research Institutes

5.4 Clinical Research Organizations

5.5 Healthcare Providers

6. AI In Pharma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global AI In Pharma Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global AI In Pharma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global AI In Pharma Market Size, Comparisons And Growth Rate Analysis

7.3. Global AI In Pharma Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global AI In Pharma Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global AI In Pharma Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. AI In Pharma Market Segmentation

9.1. Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

9.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecule, Large Molecules

9.3. Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

9.4. Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems

9.5. Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining

9.6. Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Structured Querying, Unstructured Querying, Semantic Search Technologies

9.7. Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models

10. AI In Pharma Market, Industry Metrics By Country

10.1. Global AI In Pharma Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

10.2. Global AI In Pharma Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. AI In Pharma Market Regional And Country Analysis

11.1. Global AI In Pharma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11.2. Global AI In Pharma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific AI In Pharma Market

12.1. Asia-Pacific AI In Pharma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. Asia-Pacific AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China AI In Pharma Market

13.1. China AI In Pharma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. China AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India AI In Pharma Market

14.1. India AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan AI In Pharma Market

15.1. Japan AI In Pharma Market Overview

15.2. Japan AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia AI In Pharma Market

16.1. Australia AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia AI In Pharma Market

17.1. Indonesia AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea AI In Pharma Market

18.1. South Korea AI In Pharma Market Overview

18.2. South Korea AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan AI In Pharma Market

19.1. Taiwan AI In Pharma Market Overview

19.2. Taiwan AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia AI In Pharma Market

20.1. South East Asia AI In Pharma Market Overview

20.2. South East Asia AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe AI In Pharma Market

21.1. Western Europe AI In Pharma Market Overview

21.2. Western Europe AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK AI In Pharma Market

22.1. UK AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany AI In Pharma Market

23.1. Germany AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France AI In Pharma Market

24.1. France AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy AI In Pharma Market

25.1. Italy AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain AI In Pharma Market

26.1. Spain AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe AI In Pharma Market

27.1. Eastern Europe AI In Pharma Market Overview

27.2. Eastern Europe AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia AI In Pharma Market

28.1. Russia AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America AI In Pharma Market

29.1. North America AI In Pharma Market Overview

29.2. North America AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA AI In Pharma Market

30.1. USA AI In Pharma Market Overview

30.2. USA AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada AI In Pharma Market

31.1. Canada AI In Pharma Market Overview

31.2. Canada AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America AI In Pharma Market

32.1. South America AI In Pharma Market Overview

32.2. South America AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil AI In Pharma Market

33.1. Brazil AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East AI In Pharma Market

34.1. Middle East AI In Pharma Market Overview

34.2. Middle East AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa AI In Pharma Market

35.1. Africa AI In Pharma Market Overview

35.2. Africa AI In Pharma Market, Segmentation By Technology, Segmentation By Drug Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. AI In Pharma Market Regulatory and Investment Landscape

37. AI In Pharma Market Competitive Landscape And Company Profiles

37.1. AI In Pharma Market Competitive Landscape And Market Share 2024

37.1.1. Top 10 Companies (Ranked by revenue/share)

37.2. AI In Pharma Market - Company Scoring Matrix

37.2.1. Market Revenues

37.2.2. Product Innovation Score

37.2.3. Brand Recognition

37.3. AI In Pharma Market Company Profiles

37.3.1. Concerto HealthAI Overview, Products and Services, Strategy and Financial Analysis

37.3.2. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.3. OWKIN Overview, Products and Services, Strategy and Financial Analysis

37.3.4. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

37.3.5. PathAI Overview, Products and Services, Strategy and Financial Analysis

38. AI In Pharma Market Other Major And Innovative Companies

Insilico Medicine, Exscientia, Microsoft Corporation, XtalPi, Intel, Standigm, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., DeepMind, GlaxoSmithKline, Sanofi, Bayer, Renalytix AI, Merck, AstraZeneca

39. Global AI In Pharma Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The AI In Pharma Market

41. AI In Pharma Market High Potential Countries, Segments and Strategies

41.1. AI In Pharma Market In 2030 - Countries Offering Most New Opportunities

41.2. AI In Pharma Market In 2030 - Segments Offering Most New Opportunities

41.3. AI In Pharma Market In 2030 - Growth Strategies

41.3.1. Market Trend Based Strategies

41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global AI In Pharma Market, Overview Of Key Products - Product Examples

Table 2: Global AI In Pharma Market Attractiveness, Factor-Wise Evaluation

Table 3: Global AI In Pharma Market, Supply Chain Analysis

Table 4: Global AI In Pharma Market, Major Raw Material Providers

Table 5: Global AI In Pharma Market, Major Resource Providers

Table 6: Global AI In Pharma Market, Major Manufacturers (Suppliers)

Table 7: Global AI In Pharma Market, Major Distributors And Channel Partners

Table 8: Global AI In Pharma Market, Key Technologies & Future Trends

Table 9: Global AI In Pharma Market, Major Trends

Table 10: Global AI In Pharma Market, Major End Users

Table 11: Global AI In Pharma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global AI In Pharma Historic Market Growth, 2020-2025, $ Billion

Table 13: Global AI In Pharma Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global AI In Pharma Market - TAM, US$ Billion, 2025

Table 15: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global AI In Pharma Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

Table 23: Global AI In Pharma Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

Table 24: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global AI In Pharma Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global AI In Pharma Market - Company Scoring Matrix

Table 100: Concerto HealthAI Financial Performance

Table 101: Alphabet Inc. Financial Performance

Table 102: OWKIN Financial Performance

Table 103: Nvidia Corporation Financial Performance

Table 104: PathAI Financial Performance

Table 105: Global AI In Pharma Market, Competitive Benchmarking (In USD Billions)

Table 106: Global AI In Pharma Market, Competitive Dashboard

Table 107: Global AI In Pharma Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 109: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 110: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global AI In Pharma Market, Overview Of Key Products - Product Examples

Figure 2: Global AI In Pharma Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global AI In Pharma Market, Supply Chain Analysis

Figure 4: Global AI In Pharma Market, Major Raw Material Providers

Figure 5: Global AI In Pharma Market, Major Resource Providers

Figure 6: Global AI In Pharma Market, Major Manufacturers (Suppliers)

Figure 7: Global AI In Pharma Market, Major Distributors And Channel Partners

Figure 8: Global AI In Pharma Market, Key Technologies & Future Trends

Figure 9: Global AI In Pharma Market, Major Trends

Figure 10: Global AI In Pharma Market, Major End Users

Figure 11: Global AI In Pharma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global AI In Pharma Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global AI In Pharma Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global AI In Pharma Market - TAM, US$ Billion, 2025

Figure 15: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global AI In Pharma Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

Figure 23: Global AI In Pharma Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

Figure 24: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global AI In Pharma Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global AI In Pharma Market - Company Scoring Matrix

Figure 100: Concerto HealthAI Financial Performance

Figure 101: Alphabet Inc. Financial Performance

Figure 102: OWKIN Financial Performance

Figure 103: Nvidia Corporation Financial Performance

Figure 104: PathAI Financial Performance

Figure 105: Global AI In Pharma Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global AI In Pharma Market, Competitive Dashboard

Figure 107: Global AI In Pharma Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 109: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 110: Global, AI In Pharma Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Explore growth forecasts and key drivers in the global self-learning AI and reinforcement learning market.

Explore how serverless architecture is revolutionizing the global serverless computing platforms market.

Get insights on the global Kitchen Remodel Services Market including latest trends, forecasts, and key statistics from The Business Research Company.

Get insights on the global LLMs In Cybersecurity Market including latest trends, forecasts, and key statistics from The Business Research Company.

Top Growth Trends in the Airborne Telemetry Market: Insights into Market Size and Opportunities for 2025-2034

Neuromodulation Market Report 2026 - Global Outlook – By Technology (Internal Neuromodulation, External Neuromodulation (Non-invasive)), By Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial), ...

AI In Pharma Market Report 2026 - Global Outlook – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Di...

Haptic Technology Market Report 2026 - Global Outlook – By Component (Solution, Software), By Device Type (Active Haptics, Passive Haptics), By Feedback Type (Tactile, Force), By Touch Screen Technology Type (Capacitive,...

Embedded Field-Programmable Gate Array (FPGA) Market Report 2026 - Global Outlook – By Type ( Electrically Erasable Programmable Read-Only Memory, Antifuse, Static Random Access Memory, Other Types), By Technology ( Very...

Flow Meter Market Report 2026 - Global Outlook – By Type ( Differential Pressure, Positive Displacement, Ultrasonic, Turbine, Magnetic, Coriolis, Vortex, Other Types ), By Power Type ( Electric, Solar, Battery Powered ),...

Pulse Oximeter Market Report 2026 - Global Outlook – By Product Type (Fingertip, Handheld, Wrist-worn, Table-Top And Bedside), By Technology (Conventional, Connected), By Age Group (Adult, Pediatric), By End-User (Hospit...

Medical Device Technologies Market Report 2026 - Global Outlook – By Type (Molecular Diagnostics, Diagnostic Imaging, Non-Invasive Monitoring, Drug Delivery, Mobility Aid Technologies, Micro Fluids And MEMS, Bio-Implants...

Frequently Asked Questions

How big is the AI In Pharma Market?

The AI In Pharma market was valued at $3.78 billion in 2025, increased to $4.79 billion in 2026, and is projected to reach $11.12 billion by 2030.

What is the AI In Pharma market growth?

The global AI In Pharma market is expected to grow at a CAGR of 23.4% from 2026 to 2035 to reach $11.12 billion by 2035.

Who are the key players in AI In Pharma market?

Some Key Players in the AI In Pharma market Include, Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Sciences; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; iNNOHEALTH Technology Solutions .

What is the anticipated growth trend for the AI In Pharma market?

Major trend in this market includes: Companies Embrace Generative AI In Pharma To Enhance Patient Interactions And Record Management. For further insights on this market. request a sample here

Which region has the most growth potential in the AI In Pharma market?

North America was the largest region in the AI in pharma market in 2025. The regions covered in the AI in pharma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.